title: Prader-Willi Syndrome, Management of Impulsivity, and Hyperphagia in an Adolescent.
abstract: The aim of this article is to review related literature on management of hyperphagia and impulsive behaviors in Prader-Willi syndrome (PWS) that includes either naltrexone or bupropion. In this article we also discuss a case of a 13-year-old female with PWS struggling with some behavioral and psychiatric symptoms.
authors.affiliation: 1 Institute of Living Hartford , Hartford, Connecticut.
authors.forename: M Rehan
authors.initials: MR
authors.lastname: Puri
authors.affiliation: 1 Institute of Living Hartford , Hartford, Connecticut.
authors.forename: Robert
authors.initials: R
authors.lastname: Sahl
authors.affiliation: 2 St. Georges , Great River, New York.
authors.forename: Shawwna
authors.initials: S
authors.lastname: Ogden
authors.affiliation: 1 Institute of Living Hartford , Hartford, Connecticut.
authors.forename: Salma
authors.initials: S
authors.lastname: Malik
mesh_terms: D000293:Adolescent; D019440:Anti-Obesity Agents / Q000008:administration & dosage; D016642:Bupropion / Q000008:administration & dosage; D004338:Drug Combinations; D005260:Female; D006801:Humans; D006963:Hyperphagia / Q000188:drug therapy* / Q000209:etiology; D007175:Impulsive Behavior / Q000187:drug effects*; D009271:Naltrexone / Q000008:administration & dosage; D011218:Prader-Willi Syndrome / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D019440:Anti-Obesity Agents; D004338:Drug Combinations; C000591595:bupropion hydrochloride, naltrexone hydrochoride drug combination; D016642:Bupropion; D009271:Naltrexone